Agilent Technologies, Inc. (A) stock
ANYSELaboratory Analytical InstrumentsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 1, 2026Score 21/3023% above fair value
$173.01−3.94 (-2.23%)
Close on Nov 12, 2026Market cap $48.78BP/E 34.1Yield 0.57%
Agilent Technologies r&d expenses
Research and development expenses are spending on new products and technology.
Agilent Technologies's R&D Expenses for the twelve months ending Jul 31, 2026 was $485.00M, up 8.5% year over year. For fiscal 2025 it was $455.00M, down 5.0% from the year before. Over ten years it grew 3.3% a year on average. The highest annual figure on record is $704.00M in fiscal 2008.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $455.00M | -5.0% |
| FY2024 | Oct 31, 2024 | $479.00M | -0.4% |
| FY2023 | Oct 31, 2023 | $481.00M | +3.0% |
| FY2022 | Oct 31, 2022 | $467.00M | +5.9% |
| FY2021 | Oct 31, 2021 | $441.00M | -10.9% |
| FY2020 | Oct 31, 2020 | $495.00M | +22.5% |
| FY2019 | Oct 31, 2019 | $404.00M | +4.4% |
| FY2018 | Oct 31, 2018 | $387.00M | +13.5% |
| FY2017 | Oct 31, 2017 | $341.00M | +3.6% |
| FY2016 | Oct 31, 2016 | $329.00M | -0.3% |
| FY2015 | Oct 31, 2015 | $330.00M | -7.8% |
| FY2014 | Oct 31, 2014 | $358.00M | +6.2% |
| FY2013 | Oct 31, 2013 | $337.00M | -49.6% |
| FY2012 | Oct 31, 2012 | $668.00M | +2.9% |
| FY2011 | Oct 31, 2011 | $649.00M | +6.0% |
| FY2010 | Oct 31, 2010 | $612.00M | -4.7% |
| FY2009 | Oct 31, 2009 | $642.00M | -8.8% |
| FY2008 | Oct 31, 2008 | $704.00M | +2.8% |
| FY2007 | Oct 31, 2007 | $685.00M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | $123.00M | +10.8% |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $126.00M | +12.5% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $117.00M | +3.5% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $119.00M | +7.2% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $111.00M | -12.6% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $112.00M | -0.9% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $113.00M | -11.7% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $111.00M | -2.6% |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | $127.00M | +7.6% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $113.00M | -10.3% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $128.00M | +4.1% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $114.00M | -4.2% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $118.00M | +1.7% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $126.00M | +9.6% |
| Q1 FY2023CQ4 2022 | Jan 31, 2023 | $123.00M | +5.1% |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $119.00M | +2.6% |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | $116.00M | +2.7% |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | $115.00M | +5.5% |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | $117.00M | +13.6% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $116.00M | +13.7% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $113.00M | +22.8% |
| Q2 FY2021CQ1 2021 | Apr 30, 2021 | $109.00M | -44.7% |
| Q1 FY2021CQ4 2020 | Jan 31, 2021 | $103.00M | -1.0% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $102.00M | 0.0% |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | $92.00M | -8.9% |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $197.00M | +99.0% |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $104.00M | +2.0% |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $102.00M | -1.9% |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $101.00M | +4.1% |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | $99.00M | +7.6% |
| Q1 FY2019CQ4 2018 | Jan 31, 2019 | $102.00M | +8.5% |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $104.00M | +14.3% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | $97.00M | +11.5% |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | $92.00M | +9.5% |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | $94.00M | +19.0% |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $91.00M | +8.3% |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | $87.00M | – |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | $84.00M | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | $79.00M | – |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | $84.00M | – |
See a number that looks wrong?